# KIORA PHARMACEUTICALS INC > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:d3fe55ce-f845-4c74-a012-cd513cdf7575 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/kiora-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 23 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-24T04:48:05.383419+00:00 | | Last reviewed | 2026-10-24T04:48:05.383419+00:00 | ## Identity - Legal name: KIORA PHARMACEUTICALS INC - Display name: KIORA PHARMACEUTICALS INC ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-24T04:48:05.383419+00:00 | | Completeness | 0.409 | | Record Quality | 0.834 | | Directors | 7 | | Committees | 6 | | Governance events | 16 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Aron Shapiro: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:5 - Brian M. Strem, Ph.D.: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:6 - Carmine N. Stengone: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member). claim_id=alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:7 - David Hollander, MD, MBA: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Nominating and Governance (chair); Nominating and Governance · Chair (member). claim_id=alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:8 - Erin Parsons: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Compensation (chair); Compensation · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:9 - Lisa Walters-Hoffert: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:10 - Praveen Tyle, Ph.D.: Director. Status: current. Independent: true. Since: 2008-01-01. claim_id=alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:11 ## Committees - Audit (audit). Chair: Lisa Walters-Hoffert. Members: Lisa Walters-Hoffert (chair, current); Carmine N. Stengone (member, current). committee_id=alpha:committee:kiora-pharmaceuticals-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Lisa Walters-Hoffert (member, current). committee_id=alpha:committee:kiora-pharmaceuticals-inc:audit-chair-compensation - Compensation (compensation). Chair: Erin Parsons. Members: Erin Parsons (chair, current); Lisa Walters-Hoffert (member, current). committee_id=alpha:committee:kiora-pharmaceuticals-inc:compensation - Compensation · Chair; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Erin Parsons (member, current). committee_id=alpha:committee:kiora-pharmaceuticals-inc:compensation-chair-nominating-and-governance - Nominating and Governance (nominating_governance). Chair: David Hollander, MD, MBA. Members: David Hollander, MD, MBA (chair, current); Erin Parsons (member, current). committee_id=alpha:committee:kiora-pharmaceuticals-inc:nominating-and-governance - Nominating and Governance · Chair (nominating_governance). Chair: NOT_PUBLISHED. Members: David Hollander, MD, MBA (member, current). committee_id=alpha:committee:kiora-pharmaceuticals-inc:nominating-and-governance-chair ## Executive leadership - Brian M. Strem, Ph.D.: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:12 - Melissa Tosca, CPA: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:13 ## Governance events - CEO_CHANGED: Brian M. Strem, Ph.D. executive of KIORA PHARMACEUTICALS INC, effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:hpnx2ak3jp26 - CFO_CHANGED: Melissa Tosca, CPA executive of KIORA PHARMACEUTICALS INC, effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:1ew5df71wj7zw9 - DIRECTOR_APPOINTED: Lisa Walters-Hoffert seat on KIORA PHARMACEUTICALS INC, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:1oy1gh81mdbyci - COMMITTEE_CREATED: Audit · Chair; Compensation committee of KIORA PHARMACEUTICALS INC, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:1i4cof0rf3uqi - COMMITTEE_MEMBER_ADDED: Lisa Walters-Hoffert member of Audit · Chair; Compensation, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:1lkqa9o1v0qwbq - DIRECTOR_APPOINTED: Carmine N. Stengone seat on KIORA PHARMACEUTICALS INC, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:1mqb6q7viqmuf - COMMITTEE_MEMBER_ADDED: Carmine N. Stengone member of Audit, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:uhvkg1yqbd11 - DIRECTOR_APPOINTED: Erin Parsons seat on KIORA PHARMACEUTICALS INC, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:gb5psg1c0slew - COMMITTEE_CREATED: Compensation · Chair; Nominating and Governance committee of KIORA PHARMACEUTICALS INC, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:1hq5o0rb6vwo - COMMITTEE_MEMBER_ADDED: Erin Parsons member of Compensation · Chair; Nominating and Governance, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:1i5vtyq18pywl6 - DIRECTOR_APPOINTED: Aron Shapiro seat on KIORA PHARMACEUTICALS INC, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:j8rodv8a6tzr - DIRECTOR_APPOINTED: Brian M. Strem, Ph.D. seat on KIORA PHARMACEUTICALS INC, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:wxnv3iq83ti0 - DIRECTOR_APPOINTED: David Hollander, MD, MBA seat on KIORA PHARMACEUTICALS INC, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:1mvj03w1gkqeeu - COMMITTEE_CREATED: Nominating and Governance · Chair committee of KIORA PHARMACEUTICALS INC, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:147blrm1s5zq5m - COMMITTEE_MEMBER_ADDED: David Hollander, MD, MBA member of Nominating and Governance · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:1rt3x6n1e27rl1 - DIRECTOR_APPOINTED: Praveen Tyle, Ph.D. seat on KIORA PHARMACEUTICALS INC, effective 2008-01-01. Effective: 2008-01-01. Detected: 2026-10-24T04:48:05.383419+00:00. event_id=alpha:event:transition:9x7g2vb3z8g5 ## Scoped resources - `alpha://company/kiora-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record - `alpha://company/kiora-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/kiora-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/kiora-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=board - `alpha://company/kiora-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/kiora-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/kiora-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/kiora-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/kiora-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/kiora-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/kiora-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/kiora-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/kiora-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/kiora-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/kiora-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/kiora-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/kiora-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/kiora-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/kiora-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/kiora-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=events - `alpha://company/kiora-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/kiora-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/kiora-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:lisa-walters-hoffert","name":"Lisa Walters-Hoffert"},"source_id":"board_seats"}` - Claim alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:carmine-stengone","name":"Carmine N. Stengone"},"source_id":"board_seats"}` - Claim alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:erin-parsons","name":"Erin Parsons"},"source_id":"board_seats"}` - Claim alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:lisa-walters-hoffert","name":"Lisa Walters-Hoffert"},"source_id":"board_seats"}` - Claim alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:david-hollander-md-mba","name":"David Hollander, MD, MBA"},"source_id":"board_seats"}` - Claim alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:erin-parsons","name":"Erin Parsons"},"source_id":"board_seats"}` ## Leadership - Aron Shapiro: Director. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:5. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49. - Brian M. Strem, Ph.D.: Director. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:6. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49. - Carmine N. Stengone: Director, Audit. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:7. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49. - David Hollander, MD, MBA: Director, Nominating and Governance · Chair. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49. - Erin Parsons: Director, Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:9. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49. - Lisa Walters-Hoffert: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:10. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49. - Praveen Tyle, Ph.D.: Director. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:11. Valid from: 2008-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49. - Brian M. Strem, Ph.D.: President and Chief Executive Officer. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:12. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:434fefa119fd890d6372a79e5b99737e46e8ce5c412af8804f4ee76ba9ee3f7f. - Melissa Tosca, CPA: Chief Financial Officer. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:leadership_role:13. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1869ac78a81b79697eb5de31e480aa9c176f6c7836cf74af0bd0e032f9202402. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Lisa Walters-Hoffert; Members Lisa Walters-Hoffert (Chair); Carmine N. Stengone. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_record:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:17fc8d2c2c50f82c02daa368e12bdc9edc5c88b7f99c1723906b941e50b290cf. - Compensation: Chair Erin Parsons; Members Erin Parsons (Chair); Lisa Walters-Hoffert. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:17fc8d2c2c50f82c02daa368e12bdc9edc5c88b7f99c1723906b941e50b290cf. - Nominating and Governance: Chair David Hollander, MD, MBA; Members David Hollander, MD, MBA (Chair); Erin Parsons. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:17fc8d2c2c50f82c02daa368e12bdc9edc5c88b7f99c1723906b941e50b290cf. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - KIORA PHARMACEUTICALS INC. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:56e723fcff1e2f9592c1bce5073f97585bac4cad0f397c017974378666c1c0f6. ## Entity Status - Public listing published. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:56e723fcff1e2f9592c1bce5073f97585bac4cad0f397c017974378666c1c0f6. ## Published Fact - US. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:56e723fcff1e2f9592c1bce5073f97585bac4cad0f397c017974378666c1c0f6. ## Committee Appointment - Lisa Walters-Hoffert: chair, Audit. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:17fc8d2c2c50f82c02daa368e12bdc9edc5c88b7f99c1723906b941e50b290cf. - Carmine N. Stengone: member, Audit. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:17fc8d2c2c50f82c02daa368e12bdc9edc5c88b7f99c1723906b941e50b290cf. - Erin Parsons: chair, Compensation. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:17fc8d2c2c50f82c02daa368e12bdc9edc5c88b7f99c1723906b941e50b290cf. - Lisa Walters-Hoffert: member, Compensation. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:17fc8d2c2c50f82c02daa368e12bdc9edc5c88b7f99c1723906b941e50b290cf. - David Hollander, MD, MBA: chair, Nominating and Governance. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:17fc8d2c2c50f82c02daa368e12bdc9edc5c88b7f99c1723906b941e50b290cf. - Erin Parsons: member, Nominating and Governance. Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:17fc8d2c2c50f82c02daa368e12bdc9edc5c88b7f99c1723906b941e50b290cf. ## Security Listing - KPHMW (OTC). Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:56e723fcff1e2f9592c1bce5073f97585bac4cad0f397c017974378666c1c0f6. - KPRX (NASDAQ). Claim: alpha:claim:company:d3fe55ce-f845-4c74-a012-cd513cdf7575:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:56e723fcff1e2f9592c1bce5073f97585bac4cad0f397c017974378666c1c0f6. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:56e723fcff1e2f9592c1bce5073f97585bac4cad0f397c017974378666c1c0f6: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc). - alpha:projection-evidence:document:c9a2fe65cd52c3c289fae6273a0172733d532b650f22052cc97e9b825fb5cb49: [KIORA PHARMACEUTICALS INC DEF 14A 2025-04-30](https://www.sec.gov/Archives/edgar/data/1372514/000137251425000038/kprx-20250429.htm). - alpha:projection-evidence:document:434fefa119fd890d6372a79e5b99737e46e8ce5c412af8804f4ee76ba9ee3f7f: [KPRX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000040/kprx-20260430.htm). - alpha:projection-evidence:document:1869ac78a81b79697eb5de31e480aa9c176f6c7836cf74af0bd0e032f9202402: [KPRX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1372514/000137251426000040/kprx-20260430.htm). - alpha:projection-evidence:17fc8d2c2c50f82c02daa368e12bdc9edc5c88b7f99c1723906b941e50b290cf: [Audit](https://www.sec.gov/Archives/edgar/data/1372514/000137251425000038/kprx-20250429.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/kiora-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/kiora-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/kiora-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/kiora-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-24T16:05:43.205213+00:00; recorded 2026-10-24T16:05:43.205213+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.